{"entity":{"type":"insider","cik":"0001265784","url":"/insider/0001265784","json_url":"/insider/0001265784.json","name":"LARUE WILLIAM R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":8,"first":"2011-11-22","last":"2023-01-19","span_basis":"filed_date"},"name_variants":[{"name":"LARUE WILLIAM R","source":"filing","n_filings":8,"first_seen":"2011-11-22","last_seen":"2023-01-19"}],"transactions":[{"id":8104482,"accession":"0001209191-23-003933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-003933","line_url":"/filing/0001209191-23-003933#line-1","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120.0,"shares_display":"120","price_per_share":1.2553,"price_display":"1.26","price_state":"stated","total_value":150.636,"total_display":"150.64","shares_owned_after":7763.0,"shares_owned_after_display":"7,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2023-01-19","scope":"insider"},{"id":5251899,"accession":"0001209191-21-048271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048271","line_url":"/filing/0001209191-21-048271#line-1","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6545.0,"shares_display":"6,545","price_per_share":3.82,"price_display":"3.82","price_state":"stated","total_value":25001.9,"total_display":"25,001.90","shares_owned_after":7883.0,"shares_owned_after_display":"7,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-27","scope":"insider"},{"id":4659042,"accession":"0001209191-17-037967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-037967","line_url":"/filing/0001209191-17-037967#line-1","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":2.693,"price_display":"2.69","price_state":"stated","total_value":6732.5,"total_display":"6,732.50","shares_owned_after":13388.0,"shares_owned_after_display":"13,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-02","filed_date":"2017-06-05","scope":"insider"},{"id":5231022,"accession":"0001209191-13-057723","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-057723","line_url":"/filing/0001209191-13-057723#line-2","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Officer (SVP, CFO, Treas, Asst Sec)","officer_title":"SVP, CFO, Treas, Asst Sec","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":9.12,"price_display":"9.12","price_state":"stated","total_value":77520.0,"total_display":"77,520.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-17","filed_date":"2013-12-18","scope":"insider"},{"id":5453379,"accession":"0001209191-13-052926","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-052926","line_url":"/filing/0001209191-13-052926#line-4","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Officer (SVP, CFO, Treas, Asst Sec)","officer_title":"SVP, CFO, Treas, Asst Sec","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":7.6,"price_display":"7.60","price_state":"stated","total_value":68400.0,"total_display":"68,400.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-18","scope":"insider"},{"id":5453373,"accession":"0001209191-13-052926","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-052926","line_url":"/filing/0001209191-13-052926#line-2","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Officer (SVP, CFO, Treas, Asst Sec)","officer_title":"SVP, CFO, Treas, Asst Sec","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":194400.0,"total_display":"194,400.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-18","scope":"insider"},{"id":5430370,"accession":"0001209191-13-037009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-037009","line_url":"/filing/0001209191-13-037009#line-2","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Officer (SVP, CFO, Treas, Asst Sec)","officer_title":"SVP, CFO, Treas, Asst Sec","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":7.2554,"price_display":"7.26","price_state":"stated","total_value":65298.6,"total_display":"65,298.60","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-17","filed_date":"2013-07-17","scope":"insider"},{"id":4985355,"accession":"0001209191-13-033946","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-033946","line_url":"/filing/0001209191-13-033946#line-4","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Officer (SVP, CFO, Treas, Asst Sec)","officer_title":"SVP, CFO, Treas, Asst Sec","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5740.0,"shares_display":"5,740","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":41328.0,"total_display":"41,328.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-27","filed_date":"2013-06-27","scope":"insider"},{"id":4985346,"accession":"0001209191-13-033946","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-033946","line_url":"/filing/0001209191-13-033946#line-2","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Officer (SVP, CFO, Treas, Asst Sec)","officer_title":"SVP, CFO, Treas, Asst Sec","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3260.0,"shares_display":"3,260","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":23472.0,"total_display":"23,472.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-25","filed_date":"2013-06-27","scope":"insider"},{"id":8911925,"accession":"0001209191-11-057743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-057743","line_url":"/filing/0001209191-11-057743#line-1","is_derivative":false,"issuer_cik":"0001265784","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001265784","owner_cik":"0001265784","owner_name":"LARUE WILLIAM R","owner_url":"/insider/0001265784","role":"Officer (SVP, CFO, Treas, Asst Sec)","officer_title":"SVP, CFO, Treas, Asst Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":4.1632,"price_display":"4.16","price_state":"stated","total_value":41632.0,"total_display":"41,632.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-21","filed_date":"2011-11-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001394319","name":"Tracon Pharmaceuticals, Inc.","url":"/issuer/0001394319","role":"Director","n_filings":3,"first_seen":"2017-06-05","last_seen":"2023-01-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Officer (SVP, CFO, Treas, Asst Sec)","n_filings":5,"first_seen":"2011-11-22","last_seen":"2013-12-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001265784","retrieved_at":"2026-08-21T07:02:21+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}